Thank you, Mr. Chair.
Not only am I trying to understand, but I am also trying to put myself in the shoes of taxpayers wanting to understand how Canada negotiated its vaccine supply. Yesterday, we found out that, according to Pfizer's CEO, a third vaccine dose would probably be needed six to 12 months after the initial round, followed by a yearly booster. You negotiated with Pfizer for a vaccine that was supposed to be 95% effective against the virus with two doses. Did you get the same type of deal we see in those TV commercials, “buy two and get the third one free”?
How does this new information affect your negotiations, because it certainly changes things?
What are the scientific implications, and what do you plan to do?
Are we going to be at the mercy of pharmaceutical companies suddenly taking advantage of the situation to fill their order books?
How much will all this cost?
Are you going to skip your turn when it comes to getting the third dose of Pfizer?
I would like Ms. Anand and the NACI representative to answer.